Medivo raises $15M for mobile health; GenMark scales back revenue guidance;

@FierceMedDev: Exact raising $63.7M on rocky road to FDA approval. News | Follow @FierceMedDev

@DamianFierce: Medtronic's Infuse no better than graft procedure but more dangerous, according to independent reviews. More | Follow @DamianFierce

@MichaelGFierce: Check out our new FierceBiotech LinkedIn page... and sign up to join the discussion! LinkedIn group page | Follow @MichaelGFierce

> Medical app producer Medivo picked up $15 million in venture cash to support its patient-engagement technology, bringing its total fundraising to $22 million. News

> Sorin won CE mark approval for its Reply 200 line of pacemakers, which are outfitted with technology to monitor sleep apnea. More

> LabCorp ($LH) has signed on to distribute Roche's ($RHHBY) freshly FDA approved viral load test for hepatitis C. Item

> GenMark Diagnostics ($GMNK) has scaled back its annual revenue projections to $30 million from a previously announced $35 million. Release

> Renal denervation devices may have significantly reduced blood pressure in clinical trials, but, in real-world results, the effects were less impressive. Article

Biotech News

@FierceBiotech: Analysis: Big Pharma R&D demonstrates a woeful lack of innovation. News | Follow @FierceBiotech

 @JohnCFierce: AOP spins off its 80% stake in Activartis (cancer vaccines) after Elan shareholders reject takeover bid. Release | Follow @JohnCFierce

@RyanMFierce: In $247M Transition deal, Eli Lilly is reeling in a diabetes drug candidate that it had spun off (sort of): Yesterday's item | Follow @RyanMFierce

> R&D cutbacks loom at Millennium's Cambridge ops. Item

> Teva Pharma breaks M&A silence with bite-sized MicroDose buyout. Report

> AstraZeneca picks Cambridge site as ground zero for R&D reinvention. News

> Royalty's $8B offer wilts after Elan prevails in blocking bid. Article

Pharma News

@FiercePharma: Valeant to sell $2B worth of stock to finance Bausch + Lomb buyout, plus issue $7.5B in debt. More | Follow @FiercePharma

@EricPFierce: India's Roselabs sees lots of upside in prefilled syringes for the Indian market. Story | Follow @EricPFierce

@CarlyHFierce: Bristol-Myers makes another emerging markets move with Simcere partnership in China. Yesterday's story | Follow @CarlyHFierce

> Who wins after SCOTUS pay-for-delay decision? Lawyers. More

> Want a raise, pharma reps? Get into biotech sales instead. Story

Biotech Research News

 @EmilyMFierce: Have you joined the @FierceBiotech LinkedIn group yet? Connect with biotech colleagues and join the discussion: Join now | Follow @EmilyMFierce

> Breast cancer cell growth thwarted by osteoporosis drug in preclinical studies. Report

> New genetic mutations found in families with early-onset Alzheimer's. Item

> Inovio says H7N9 bird flu vaccine effective in mice. Story

> Report: Genomics industry contributed $1 trillion to U.S. economy in last 25 years. More

Pharma Manufacturing News

> French plant part of proposed GSK, Aspen deal. Item

> Roselabs taps growth of prefilled syringe in India. Report

> City forecloses on Indiana insulin plant it helped fund. Article

> Eisai adding packaging facility to U.K. plant. More

Suggested Articles

The former CEO of the molecular testing company Foundation Medicine, Troy Cox, has been named chairman of the Swiss big data firm Sophia Genetics.

Researchers at MIT used a machine-learning algorithm to uncover the potent antibiotic properties hiding within an old small-molecule candidate.

The randomized, blinded study showed statistically significant improvements in assessments of inattention and brain activity.